-
1
-
-
0035282068
-
Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology
-
Schiffer CA, Anderson KC, Bennett CL, Bernstein S, EIting LS, Goldsmith M, et al. Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19:1519-38.
-
(2001)
J Clin Oncol
, vol.19
, pp. 1519-1538
-
-
Schiffer, C.A.1
Anderson, K.C.2
Bennett, C.L.3
Bernstein, S.4
EIting, L.S.5
Goldsmith, M.6
-
2
-
-
0028344060
-
Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs
-
Lane TA. Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs. Arch Pathol Lab Med 1994; 118:392-404.
-
(1994)
Arch Pathol Lab Med
, vol.118
, pp. 392-404
-
-
Lane, T.A.1
-
3
-
-
0028069626
-
The efficacy of leukodepletion to improve platelet transfusion response: A critical appraisal of clinical studies
-
Heddle NM. The efficacy of leukodepletion to improve platelet transfusion response: A critical appraisal of clinical studies. Transfus Med Rev 1994; 8:15-28.
-
(1994)
Transfus Med Rev
, vol.8
, pp. 15-28
-
-
Heddle, N.M.1
-
4
-
-
0028820362
-
A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant
-
Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86:3598-603.
-
(1995)
Blood
, vol.86
, pp. 3598-3603
-
-
Bowden, R.A.1
Slichter, S.J.2
Sayers, M.3
Weisdorf, D.4
Cays, M.5
Schoch, G.6
-
5
-
-
0022827429
-
Transmission of adult T-cell leukemia virus (HTLV-1) through blood transfusion and its prevention
-
Okochi K, Sato H, Transmission of adult T-cell leukemia virus (HTLV-1) through blood transfusion and its prevention. AIDS Res 1996; 2 Suppl 1:5157-561.
-
(1996)
AIDS Res
, vol.2
, Issue.SUPPL. 1
-
-
Okochi, K.1
Sato, H.2
-
6
-
-
0025866892
-
Variation in blood component irradiation practice: Implications for prevention of transfusion-associated graft-versus-host disease
-
Anderson KC, Goodnough LT, Sayers M, Pisciotto PT, Kurtz SR, Lane TA, et al. Variation in blood component irradiation practice: Implications for prevention of transfusion-associated graft-versus-host disease. Blood 1991; 77:2096-102.
-
(1991)
Blood
, vol.77
, pp. 2096-2102
-
-
Anderson, K.C.1
Goodnough, L.T.2
Sayers, M.3
Pisciotto, P.T.4
Kurtz, S.R.5
Lane, T.A.6
-
7
-
-
0031452585
-
The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia
-
Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto
-
Rebulla P, Finazzi G, Marangoni F, Awisati G, Gugliotta L, Tognoni G, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997; 337:1870-5.
-
(1997)
N Engl J Med
, vol.337
, pp. 1870-1875
-
-
Rebulla, P.1
Finazzi, G.2
Marangoni, F.3
Awisati, G.4
Gugliotta, L.5
Tognoni, G.6
-
9
-
-
0033854896
-
Platelet transfusions: Utilization and associated costs in a tertiary care hospital
-
Meehan KR, Matias CO, Rathore SS, Sandler SG, Kallich J, LaBrecque J, et al. Platelet transfusions: Utilization and associated costs in a tertiary care hospital. Am J Hematol 2000; 64:251-6.
-
(2000)
Am J Hematol
, vol.64
, pp. 251-256
-
-
Meehan, K.R.1
Matias, C.O.2
Rathore, S.S.3
Sandler, S.G.4
Kallich, J.5
LaBrecque, J.6
-
10
-
-
0347939775
-
Pharmacological therapies to minimise platelet transfusion
-
Norfolk DR, Seghatchian J. Pharmacological therapies to minimise platelet transfusion. Transfus Sci 2000; 22:149-53.
-
(2000)
Transfus Sci
, vol.22
, pp. 149-153
-
-
Norfolk, D.R.1
Seghatchian, J.2
|